ArticleInsights into imaging2026
A pre-trained foundation model framework for multiplanar MRI classification of extramural vascular invasion and mesorectal fascia invasion in rectal cancer.
Article in Insights into imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
objectivesAccurate MRI-based identification of extramural vascular invasion (EVI) and mesorectal fascia invasion (MFI) is crucial for risk-stratified rectal cancer treatment. However, subjective visual assessment and inter-institutional variability limit diagnostic consistency. This study developed and evaluated a multi-center, foundation model-driven framework that automatically classifies EVI and MFI on axial and sagittal MRI. MATERIALS AND
methodsA total of 331 pre-treatment rectal cancer T2-weighted MRI scans from three European hospitals were retrospectively recruited. A self-supervised frequency domain harmonization strategy was applied to reduce scanner variability. Three classifiers, SeResNet, the universal biomedical pretrained model (UMedPT) with a multilayer perceptron head, and a logistic-regression variant using frozen UMedPT features (UMedPT_LR), were trained (n = 265) and tested (n = 66). Gradient-weighted class activation mapping (Grad-CAM) visualized model predictions.
resultsUMedPT_LR achieved the best EVI performance with multiplanar fusion (AUC = 0.82, test set). For MFI, UMedPT trained on axial harmonized images yielded the highest performance (AUC = 0.77). Both tasks outperformed the CHAIMELEON 2024 benchmark (EVI: 0.82 vs 0.74; MFI: 0.77 vs 0.75). Harmonization enhanced MFI classification, and multiplanar fusion further boosted EVI performance. Grad-CAM confirmed biologically plausible attention on peritumoral regions (EVI) and mesorectal fascia margins (MFI).
conclusionThe proposed foundation model-driven framework, leveraging frequency domain harmonization and multiplanar fusion, achieves state-of-the-art performance for automated EVI and MFI classification on MRI, demonstrating strong generalizability across multiple centers. CRITICAL RELEVANCE STATEMENT: Addressing inter-center inconsistencies in rectal cancer MRI, a multiplanar foundation model with cross-scanner harmonization significantly improves the detection of EVI and MFI, potentially standardizing staging and guiding therapy. KEY POINTS: Among the first studies to investigate automated classification of both EVI and MFI using axial and sagittal T2-weighted MRI. Foundation model-derived features outperform conventional convolutional neural networks (CNNs) for EVI and MFI classification. Frequency domain harmonization and multiplanar fusion selectively enhance diagnostic performance. Automated prediction of EVI and MFI may support more consistent staging and clinical decision-making across institutions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.